SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001438533-19-000032
Filing Date
2019-10-10
Accepted
2019-10-10 17:16:35
Documents
14
Period of Report
2019-10-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K a8-k101019directorresi.htm   iXBRL 8-K 41292
  Complete submission text file 0001438533-19-000032.txt   188762

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rtrx-20191010.xsd EX-101.SCH 4669
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rtrx-20191010_cal.xml EX-101.CAL 703
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rtrx-20191010_def.xml EX-101.DEF 1553
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rtrx-20191010_lab.xml EX-101.LAB 27263
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rtrx-20191010_pre.xml EX-101.PRE 14193
11 EXTRACTED XBRL INSTANCE DOCUMENT a8-k101019directorresi_htm.xml XML 4411
Mailing Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130
Business Address 3721 VALLEY CENTRE DR. SUITE 200 SAN DIEGO CA 92130 760-260-8600
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36257 | Film No.: 191146663
SIC: 2834 Pharmaceutical Preparations